Based at PA Consulting’s Technology Centre
in Cambridge, Stephen Blatcher is a chartered
Mechanical Engineer who specialises in
material selection, component design and risk
management activities for surgical products
and processes. Whilst at PA, Stephen has
helped many companies develop innovative products and
processes with particular emphasis on the multidisciplinary skills
necessary for delivering combination products such as drug
eluting implants and biotherapeutic delivery devices. Stephen
has also undertaken a number of studies to understand the
technologies required to commercialise combination surgical
products and regenerative therapies.
Ian Rhodes is a member of PA’s Management
Group World Wide and leads the technology
group. His background is in the design and
development of new products, processes and
services, primarily within the healthcare and
medical industries. Ian has become widelyrecognised
for bridging the gap between commercial/business
development/strategic issues, and the implementation of
engineering/operations. He has led and provided input to a
number of due diligence assignments within the sector. Ian has
an MBA from the London Business School and more recently
was the founding CEO of Aegate Ltd, a PA venture company
which he led for the first two and a half years of its growth
and development.
Dr Angus Forster is a Principal Consultant at PA
Consulting Group, Cambridge, UK. He earned
his PhD in Pharmaceutics and BPharm from
Otago University, New Zealand. Angus has
been involved in the Pharmaceutical industry
for over 10 years and has experience in Drug
Development, Pharmaceutical Manufacturing Technology and Drug
/Device combination products. He has published over 15 articles
and presented at a number of pharmaceutical conferences on the
subject of solid dispersion formulation and characterisation.
Jennifer Vondran is an Analyst in the
Global Technology Group of the PA
Consulting Group. Jennifer’s interests include
biocompatible materials, drug delivery
design and development, tissue engineering,
medical device product development and
risk management, and nanotechnology. Prior to becoming
an analyst, Jennifer completed a dual BS/MS degree in
Biomedical and Materials Science and Engineering from
Drexel University in Philadelphia. Her research was recently
published in the Journal of Applied Polymer Science.
